PictorLabs raised $30 million in a Series B funding round led by Insight Partners to advance AI-powered virtual staining technology.
PRIVATESep 18, 2024
Amount Raised
$30 Million
Round Type
Series B
Los AngelesOtherInformation TechnologyBiotechnologySoftwareHealth CareArtificial Intelligence
Investors
M VenturesInsight Partners
Description
PictorLabs successfully completed its $30 million Series B funding round to enhance its AI-powered virtual staining technology. This funding, led by Insight Partners, will accelerate market reach and technology improvement.
Company Information
Company
Pictor Labs
Location
Los Angeles, California, United States
About
PictorLabs, Inc. is a digital pathology company developing an AI-powered virtual staining platform to revolutionize histopathology and accelerate clinical research with the goal of improving patient outcomes. Led by a team with deep expertise in bioengineering, artificial intelligence, and health-tech product development, the Company is reimagining existing histopathology workflows, accelerating clinical and diagnostic results, and improving process sustainability. From a single unstained tissue sample, PictorLabs’ proprietary platform can produce an unlimited number of virtual stains that are indistinguishable from analogous chemical stains. PictorLabs is developing products that replicate standard of care stains and is creating specialized virtual biomarker stains for indications in which there is a large demand for novel and accelerated diagnostic tests.
Fundz sees it the moment Pictor Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Los AngelesOtherInformation TechnologyBiotechnologySoftwareHealth CareArtificial Intelligence